Transcat Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Transcat heeft een totaal eigen vermogen van $268.8M en een totale schuld van $3.0M, wat de schuld-eigenvermogensverhouding op 1.1% brengt. De totale activa en totale passiva bedragen respectievelijk $323.6M en $54.8M. De EBIT Transcat is $24.0M waardoor de rentedekking -20.9 is. Het heeft contanten en kortetermijnbeleggingen van $23.8M.

Belangrijke informatie

1.1%

Verhouding schuld/eigen vermogen

US$3.00m

Schuld

Rente dekkingsratio	-20.9x
Contant	US$23.82m
Aandelen	US$268.76m
Totaal verplichtingen	US$54.80m
Totaal activa	US$323.55m

Recente financiële gezondheidsupdates

Does Transcat (NASDAQ:TRNS) Have A Healthy Balance Sheet?

May 21

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

Aug 05

Recent updates

There Are Reasons To Feel Uneasy About Transcat's (NASDAQ:TRNS) Returns On Capital

Dec 19

Transcat's (NASDAQ:TRNS) Problems Go Beyond Weak Profit

Nov 08

Capital Allocation Trends At Transcat (NASDAQ:TRNS) Aren't Ideal

Aug 03

Transcat (NASDAQ:TRNS) Hasn't Managed To Accelerate Its Returns

Apr 06

Are Transcat, Inc. (NASDAQ:TRNS) Investors Paying Above The Intrinsic Value?

Oct 20

Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M

Sep 28

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

Aug 05

Transcat (NASDAQ:TRNS) Has Some Way To Go To Become A Multi-Bagger

Jul 24

What Is Transcat, Inc.'s (NASDAQ:TRNS) Share Price Doing?

Jul 13

Is Transcat, Inc. (NASDAQ:TRNS) Trading At A 38% Discount?

Jun 17

Returns At Transcat (NASDAQ:TRNS) Appear To Be Weighed Down

Apr 02

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $95.2M ) TRNS } overtreffen de korte termijn passiva ( $26.5M ).

Langlopende schulden: De kortetermijnactiva TRNS ( $95.2M ) overtreffen de langetermijnschulden ( $28.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: TRNS heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van TRNS is de afgelopen 5 jaar gedaald van 39.4% naar 1.1%.

Schuldendekking: De schuld van TRNS wordt goed gedekt door de operationele kasstroom ( 1080.8% ).

Rentedekking: TRNS verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Transcat Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Transcat (NASDAQ:TRNS) Have A Healthy Balance Sheet?

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

Recent updates

Transcat, Inc. to Report Q2, 2025 Results on Oct 28, 2024

Transcat: Growth Is Great, But Not Enough To Prevent A Bearish Outlook

Does Transcat (NASDAQ:TRNS) Deserve A Spot On Your Watchlist?

Market Participants Recognise Transcat, Inc.'s (NASDAQ:TRNS) Earnings

Transcat, Inc. to Report Q1, 2025 Results on Jul 29, 2024

Transcat, Inc., Annual General Meeting, Sep 11, 2024

Transcat (NASDAQ:TRNS) Might Be Having Difficulty Using Its Capital Effectively

Transcat (NASDAQ:TRNS) Ticks All The Boxes When It Comes To Earnings Growth

Transcat's (NASDAQ:TRNS) Promising Earnings May Rest On Soft Foundations

President recently sold US$415k worth of stock

Full year 2024 earnings released: EPS: US$1.66 (vs US$1.42 in FY 2023)

Does Transcat (NASDAQ:TRNS) Have A Healthy Balance Sheet?

Transcat, Inc. to Report Q4, 2024 Results on May 20, 2024

Some Confidence Is Lacking In Transcat, Inc.'s (NASDAQ:TRNS) P/S

Transcat, Inc. (NasdaqGM:TRNS) acquired Becnel Rental Tools, LLC for $50 million.

Transcat Stock: Time To Recalibrate

Transcat, Inc. (NasdaqGM:TRNS) acquired Becnel Rental Tools, LLC for $50 million.

Transcat, Inc. Announces Management Changes

President exercised options and sold US$439k worth of stock

President recently sold US$1.1m worth of stock

President notifies of intention to sell stock

Price target increased by 10% to US$119

Transcat Scores Wins On The Top And Bottom Lines, But Is Still Too Expensive

Transcat, Inc. Announces Board Changes

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Transcat, Inc. to Report Q3, 2024 Results on Jan 29, 2024

There Are Reasons To Feel Uneasy About Transcat's (NASDAQ:TRNS) Returns On Capital

President notifies of intention to sell stock

Independent Director recently bought US$100k worth of stock

Transcat's (NASDAQ:TRNS) Problems Go Beyond Weak Profit

Consensus EPS estimates fall by 21%

New minor risk - Earnings quality

High number of new directors

Transcat, Inc. Appoints Dawn DePerrior to the Board

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Transcat, Inc. Provides Financial Guidance for the Fiscal Year 2024

Transcat, Inc. to Report Q2, 2024 Results on Oct 30, 2023

Chief Operating Officer exercised options and sold US$144k worth of stock

Transcat, Inc. has completed a Follow-on Equity Offering in the amount of $70.000275 million.

Transcat, Inc. has completed a Follow-on Equity Offering in the amount of $70.000275 million.

Investor sentiment deteriorates as stock falls 16%

New minor risk - Shareholder dilution

President recently sold US$264k worth of stock

President notifies of intention to sell stock

Consensus EPS estimates increase by 10%

Transcat, Inc. (NasdaqGM:TRNS) acquired Axiom Test Equipment, Inc. for $38 million.

Capital Allocation Trends At Transcat (NASDAQ:TRNS) Aren't Ideal

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc., Annual General Meeting, Sep 06, 2023

Transcat, Inc. to Report Q1, 2024 Results on Jul 31, 2023

Independent Director recently sold US$301k worth of stock

Full year 2023 earnings released: EPS: US$1.42 (vs US$1.52 in FY 2022)

Transcat, Inc. to Report Q4, 2023 Results on May 22, 2023

Transcat (NASDAQ:TRNS) Hasn't Managed To Accelerate Its Returns

Insider recently sold US$90k worth of stock

Independent Director recently sold US$436k worth of stock

Price target increased by 9.5% to US$92.60

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Transcat, Inc. to Report Q3, 2023 Results on Jan 30, 2023

Consensus forecasts updated

Independent Director recently sold US$181k worth of stock

Price target increased to US$86.60

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Are Transcat, Inc. (NASDAQ:TRNS) Investors Paying Above The Intrinsic Value?

Transcat, Inc. to Report Q2, 2023 Results on Oct 31, 2022

Investor sentiment improved over the past week

Transcat, Inc. (NasdaqGM:TRNS) acquired Galium Limited for $1.2 million.

Transcat acquires Complete Calibrations for $1.2M and e2b Calibration for $3.15M

Transcat, Inc. Elects Cynthia Langston as Directors

Consensus EPS estimates increase by 11%

We Think Transcat (NASDAQ:TRNS) Can Stay On Top Of Its Debt

First quarter 2023 earnings: EPS and revenues exceed analyst expectations